We are live on
!
Find out more
Winslow Capital Management Portfolio holdings
AUM
$25.6B
1-Year Est. Return
33.75%
This Fund
S&P 500
This Quarter
Est. Return
-2.94%
1 Year Est. Return
+33.75%
3 Year Est. Return
+154.66%
5 Year Est. Return
+213.06%
10 Year Est. Return
+1,176.99%
AUM
$27.4B
AUM Growth
-$2.65B
(-8.8%)
Cap. Flow
-$1.41B
Cap. Flow
% of AUM
-5.15%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
80
New
9
Increased
26
Reduced
31
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$586M |
| 2 |
AGN
Allergan plc
AGN
|
+$448M |
| 3 |
Intuit
INTU
|
+$415M |
| 4 |
PayPal
PYPL
|
+$410M |
| 5 |
Edwards Lifesciences
EW
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$520M |
| 2 |
eBay
EBAY
|
+$486M |
| 3 |
Baidu
BIDU
|
+$464M |
| 4 |
Cognizant
CTSH
|
+$370M |
| 5 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$337M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.6% |
| 2 | Consumer Discretionary | 22.45% |
| 3 | Technology | 14.56% |
| 4 | Communication Services | 13.72% |
| 5 | Financials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$3.9T
| $1.26B | 4.61% |
40,602,440
-385,100
| -0.9% | -$11.8M |
|
2
Apple
AAPL
$4.89T
| $1.25B | 4.57% |
45,445,212
-6,229,732
| -12% | -$183M |
|
3
Visa
V
$677B
| $1.21B | 4.4% |
17,353,267
-617,867
| -3% | -$44.1M |
|
4
Amazon
AMZN
$2.5T
| $1.13B | 4.1% |
44,010,460
+9,107,860
| +26% | +$230M |
|
5
Meta Platforms (Facebook)
META
$1.51T
| $986M | 3.59% |
10,970,820
-689,036
| -6% | -$63.2M |
|
6
Nike
NKE
$61.9B
| $900M | 3.28% |
14,640,588
-517,790
| -3% | -$29.3M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $757M | 2.76% |
6,996,437
+283,645
| +4% | +$35.2M |
|
8
Adobe
ADBE
$89.5B
| $694M | 2.53% |
8,441,744
-298,501
| -3% | -$24.2M |
|
9
Booking.com
BKNG
$138B
| $689M | 2.51% |
13,934,750
-522,050
| -4% | -$25.9M |
|
10
Mastercard
MA
$477B
| $600M | 2.19% |
6,654,747
-236,152
| -3% | -$22.2M |
|
11
UnitedHealth
UNH
$382B
| $580M | 2.11% |
4,999,633
+331,717
| +7% | +$39.7M |
|
12
CVS Health
CVS
$137B
| $558M | 2.03% |
5,786,881
+133,059
| +2% | +$14M |
|
|
13
Bristol-Myers Squibb
BMY
$127B
| $546M | 1.99% |
+9,229,864
| New | +$586M |
|
14
Home Depot
HD
$332B
| $534M | 1.95% |
4,623,626
+811,817
| +21% | +$93.9M |
|
|
LNKD
15
DELISTED
LinkedIn Corporation
LNKD
| $530M | 1.93% |
2,788,435
+1,004,662
| +56% | +$199M |
|
16
American Tower
AMT
$77.7B
| $510M | 1.86% |
5,800,507
+97,331
| +2% | +$9.16M |
|
17
Starbucks
SBUX
$118B
| $504M | 1.84% |
8,861,117
-813,140
| -8% | -$45.6M |
|
|
ALXN
18
DELISTED
Alexion Pharmaceuticals
ALXN
| $502M | 1.83% |
3,211,156
+321,355
| +11% | +$58.6M |
|
19
Walt Disney
DIS
$165B
| $491M | 1.79% |
4,806,773
-749,871
| -13% | -$81.7M |
|
20
McKesson
MCK
$98.5B
| $452M | 1.65% |
2,444,166
-371,711
| -13% | -$78.8M |
|
21
Bausch Health
BHC
$1.65B
| $452M | 1.65% |
2,533,617
+667,755
| +36% | +$156M |
|
22
Delta Air Lines
DAL
$55.9B
| $434M | 1.58% |
9,682,569
-337,542
| -3% | -$15.2M |
|
23
SBA Communications
SBAC
$18.4B
| $426M | 1.55% |
4,062,734
-145,456
| -3% | -$17M |
|
24
IQVIA
IQV
$34.7B
| $424M | 1.54% |
6,090,744
+1,566,786
| +35% | +$117M |
|
25
Danaher
DHR
$135B
| $408M | 1.49% |
7,119,306
+1,857,655
| +35% | +$110M |
|
Similar funds
UIM
VAI
KK
Winslow Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Winslow Capital Management held 80 positions worth $27.4B, down 8.8% from $30.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Winslow Capital Management withdrew a net $1.41B in Q3 2015, closing 12 positions and reducing 31 holdings. Its most notable exit was Biogen, an estimated $520M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Winslow Capital Management opened a new position in Bristol-Myers Squibb worth $546M.
- Winslow Capital Management's largest Q3 2015 buy was Bristol-Myers Squibb: 9,229,864 shares worth $546M.
- Winslow Capital Management added most to Amazon in Q3 2015, an estimated $230M increase.
- Winslow Capital Management's biggest Q3 2015 reduction was Cognizant, cutting an estimated $370M.
- Winslow Capital Management fully exited Biogen in Q3 2015, selling an estimated $520M.
- Winslow Capital Management's ten largest holdings make up 35% of its $27.4B portfolio in Q3 2015.
- Winslow Capital Management opened 9 new positions and closed 12 in Q3 2015.
- Winslow Capital Management's portfolio value fell 8.8% quarter-over-quarter to $27.4B.
Based on Winslow Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.